What is Pharmright?
Pharmright is the company behind the LiviPod, an innovative system designed for comprehensive medication and supplement management. The LiviPod system caters to a broad user base, including individuals managing their own health regimens, caregivers overseeing the well-being of others, and those requiring assistance with daily supplement intake. Its modular and adaptable design allows for personalized medication management experiences, notably without any recurring subscription fees. Key features include real-time alerts, automated reminders, and an intuitive mobile application, all aimed at simplifying wellness routines and significantly enhancing adherence to prescribed medication schedules.
How much funding has Pharmright raised?
Pharmright has raised a total of $3M across 3 funding rounds:
Private Equity
$902K
Series A
$1.2M
Private Equity
$865K
Private Equity (2014): $902K, investors not publicly disclosed
Series A (2015): $1.2M led by SCRA and Upstate Carolina Angel Network
Private Equity (2016): $865K, investors not publicly disclosed
Key Investors in Pharmright
SCRA
SCRA is a public, non-profit entity focused on stimulating South Carolina's innovation economy through funding and support for technology startups, academic institutions, and industry collaborations. They provide essential resources like workspace, coaching, and access to networks for emerging companies and research initiatives.
Upstate Carolina Angel Network
The Upstate Carolina Angel Network is an investment group that supports early-stage companies, likely focusing on regional economic development and technological innovation within South Carolina. They provide crucial seed capital and strategic guidance to promising startups.
What's next for Pharmright?
The substantial enterprise-level capital infusion, culminating in a total funding of $3M, positions Pharmright for accelerated expansion and product development. The recent strategic investment of $865K is expected to fuel advancements in their LiviPod system, potentially broadening its market reach and enhancing its technological capabilities. This strategic backing suggests a focus on scaling operations, increasing market penetration, and solidifying its position as a leader in the medication adherence technology sector.
See full Pharmright company page
